title: Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer.
abstract: Isolated hilar and mediastinal recurrence (IMHR) following external beam radiation therapy (EBRT) in patients with lung cancer is common. These patients do not have many treatment options and are usually offered palliative chemotherapy or best supportive care. Endobronchial ultrasound (EBUS)-guided intratumoral injection of cisplatin (ITC) is a novel approach for these patients. The procedure is performed under conscious sedation. The lesion is located with a bronchoscopy using EBUS, and a 22-gauge EBUS needle is advanced through the working channel of the scope and locked in position. Under ultrasound guidance, the wall of the tracheobronchial tree is punctured and the needle is moved into the target lesion. The needle stylet is then removed and cisplatin (40 mg/40 mL) is injected into the lesion. One to two sites are treated per session. Details of the procedure are described in the protocol section of paper. At our center, 50 sites were treated in 36 patients (19 males, 17 females). The mean age of our cohort was 61.9 ±8.5 years. We performed final analyses on 35 patients and 41 sites. 24/35 (69%) had complete or partial response (responders), whereas 11/35 (31%) had stable or progressive disease (non-responders). Overall, survival in our group was 8 months (95% CI of 6-11 months), with patients who responded having significantly better survival than the ones who did not.
authors.affiliation: Division of Pulmonary/Critical care/Sleep Medicine, University of Florida College of Medicine; Hiren.Mehta@medicine.ufl.edu.
authors.forename: Hiren J
authors.initials: HJ
authors.lastname: Mehta
authors.affiliation: Division of Pulmonary/Critical care/Sleep Medicine, University of Florida College of Medicine.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Jantz
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001999:Bronchoscopy / Q000379:methods; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000000981:diagnostic imaging / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage*; D061765:Endoscopic Ultrasound-Guided Fine Needle Aspiration / Q000295:instrumentation; D019160:Endosonography / Q000379:methods*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional / Q000379:methods*; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009367:Neoplasm Staging; D011446:Prospective Studies
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin